Literature DB >> 18342802

New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage.

R Webster Crowley1, Ricky Medel, Neal F Kassell, Aaron S Dumont.   

Abstract

Cerebral vasospasm lingers as the leading preventable cause of death and disability in patients who experience aneurysmal subarachnoid hemorrhage. Despite the potentially devastating consequences of cerebral vasospasm, the mechanisms behind it are incompletely understood. Nitric oxide, endothelin-1, bilirubin oxidation products and inflammation appear to figure prominently in its pathogenesis. Therapies directed at many of these mechanisms are currently under investigation and hold significant promise for an ultimate solution to this substantial problem.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342802     DOI: 10.1016/j.drudis.2007.11.010

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  37 in total

1.  Possible Role of Raf-1 Kinase in the Development of Cerebral Vasospasm and Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats.

Authors:  Jian Zhang; Xiang Xu; Dai Zhou; Haiying Li; Wanchun You; Zhong Wang; Gang Chen
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

2.  Protective effect of estrogen in endothelin-induced middle cerebral artery occlusion in female rats.

Authors:  Michele L Glendenning; Tara Lovekamp-Swan; Derek A Schreihofer
Journal:  Neurosci Lett       Date:  2008-09-06       Impact factor: 3.046

Review 3.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

4.  Novel Actions of Nonsteroidal Anti-Inflammatory Drugs on Vascular Ion Channels: Accounting for Cardiovascular Side Effects and Identifying New Therapeutic Applications.

Authors:  Lioubov I Brueggemann; Bharath K Mani; Alexander R Mackie; Leanne L Cribbs; Kenneth L Byron
Journal:  Mol Cell Pharmacol       Date:  2010

5.  Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm.

Authors:  Ananth K Vellimana; Eric Milner; Tej D Azad; Michael D Harries; Meng-Liang Zhou; Jeffrey M Gidday; Byung Hee Han; Gregory J Zipfel
Journal:  Stroke       Date:  2011-02-11       Impact factor: 7.914

6.  Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials.

Authors:  R Loch Macdonald; Randall T Higashida; Emanuela Keller; Stephan A Mayer; Andy Molyneux; Andreas Raabe; Peter Vajkoczy; Isabel Wanke; Aline Frey; Angelina Marr; Sébastien Roux; Neal F Kassell
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

7.  Controversies and evolving new mechanisms in subarachnoid hemorrhage.

Authors:  Sheng Chen; Hua Feng; Prativa Sherchan; Damon Klebe; Gang Zhao; Xiaochuan Sun; Jianmin Zhang; Jiping Tang; John H Zhang
Journal:  Prog Neurobiol       Date:  2013-09-25       Impact factor: 11.685

8.  Cerebral inflammatory response and predictors of admission clinical grade after aneurysmal subarachnoid hemorrhage.

Authors:  Khalid A Hanafy; R Morgan Stuart; Luis Fernandez; J Michael Schmidt; Jan Claassen; Kiwon Lee; E Sander Connolly; Stephan A Mayer; Neeraj Badjatia
Journal:  J Clin Neurosci       Date:  2009-12-08       Impact factor: 1.961

9.  Hyperbaric oxygen for cerebral vasospasm and brain injury following subarachnoid hemorrhage.

Authors:  Robert P Ostrowski; John H Zhang
Journal:  Transl Stroke Res       Date:  2011-09-01       Impact factor: 6.829

10.  Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm.

Authors:  Bharath K Mani; James O'Dowd; Lalit Kumar; Lioubov I Brueggemann; Masey Ross; Kenneth L Byron
Journal:  J Cardiovasc Pharmacol       Date:  2013-01       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.